All lobbying filings

Vantive US Healthcare LLC

Vantive US Healthcare LLC filed a Q2 report for Vantive US Healthcare LLC on July 20, 2026.

Lobbying for Vantive US Healthcare LLC · Medical Technology Manufacturing

As filed: VANTIVE US HEALTHCARE LLC for VANTIVE US HEALTHCARE LLC.

All filings by Vantive US Healthcare LLC · Everything Vantive US Healthcare LLC has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$390,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Trade (domestic/foreign)

Issues related to tariffs including issues related to Section 232 investigation of medical devices. Issues related to medical technology trade.

Medicare/Medicaid

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.

Health Issues

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring

Foreign Relations

Issues related to U.S. global health program priorities

Bills named in this filing 2

H.R. 8319
KIDNEY Remote Monitoring Act
H.R. 4441
Patient Access to Innovative New Technologies Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.